1Doley B, Das AK, Das M (2001) Metastatic sweat gland carcinoma. J Assoc Physicians India 49:479-480.

2Mezger J, Remberger K, Schalhorn A, Wohlrab A, Wilmanns W (1986) Treatment of metastatic sweat gland carcinoma by a four drug combination chemotherapy: response in two cases. Med Oncol Tumor Pharmacotherapy 3:29-34.

3Chintamani1, Sharma R, Badran R, Singhal V, Saxena S, Bansal A (2003) Metastatic sweat gland adenocarcinoma: A clinico-pathological dilemma. World J Surg Oncol1:13.

4Seong MK, Kim EK, Han K, Seol H, Kim HA, Noh WC M (2015) Primary apocrine sweat gland carcinomas of the axilla: a report of two cases and a review of the literature. World J. Surg Oncol 13:59.

5Zahid R, Soofi ME, Elmalik H, Junejo K (2016) Primary apocrine carcinoma of the axilla in a male patient: a case report. Clin Case Rep 4:344-347.

6Agha RA, Fowler AJ, Saeta A, Barai I, Rajmohan S, Orgill DP (2016) SCARE Group. The SCARE statement: consensus-based surgical case reportguidelines.Int J Surg 34:180-186.

7Hollowell KL, Agle SC, Zervos EE, Fitzgerald TL (2012) Cutaneous apocrine adenocarcinoma: defining epidemiology, outcomes, and optimal therapy for a rare neoplasm. J Surg Oncol 105:415-419.

8Joseph D, Dubashi B, Basu D, Srinivasan S, Jain A (2015) Response to taxane-based chemotherapy in metastatic eccrine porocarcinoma with extensive cutaneous involvement. Indian J Cancer 52:73-74.

9Sridhar KS, Benedetto P, Otrakji CL, Charyulu KK (1989) Response of eccrine adenocarcinoma to tamoxifen.Cancer 64:366-370.

10Schroder U, Dries V, Klussmann JP, Wittekindt C, Eckel HE (2004) Successful adjuvant tamoxifen therapy for estrogen receptor-positive metastasizing sweat gland adenocarcinoma: need for a clinical trial? Ann Otol Rhinol Laryngol 113:242-244.